By Abhishek Vishnoi
MUMBAI (Reuters) - The BSE Sensex fell 1 percent on Wednesday, retreating from its highest close in 2-1/2 years in the previous session, as lenders slumped after the Reserve Bank of India (RBI) further tightened cash conditions to shore up the rupee.
The BSE's sub-index of banking stocks has slumped 9.2 percent since the RBI first moved to squeeze liquidity on July 15, compared to a rise of 0.3 percent in the benchmark index over the same period.
The RBI took new steps on Tuesday to support the rupee, including lowering the overall limit for borrowing under the daily liquidity adjustment facility.
Analysts worry that the failure to stabilise the rupee could lead the central bank to announce stronger measures such as an increase in the cash reserve ratio or even an outright hike in the policy rate.
"Markets sold off sharply on the back of fresh RBI measures.
More From This Section
In the next few days, focus would be on the RBI monetary policy meeting," said Sanjeev Zarbade, vice president of private client group research at Kotak Securities.
The BSE Sensex fell 1.04 percent, or 211.45 points, to end at 20,090.68, snapping five consecutive sessions of gains. The index had closed at its highest since January 4, 2011 on Tuesday.
The Nifty fell 1.44 percent, or 87.30 points, to end at 5,990.50, marking its biggest daily fall since July 3.
Lenders dependent on wholesale short-term funding fell the most following the RBI's new liquidity steps.
IndusInd Bank Ltd
Shares in state-owned banks also fell as a drop in bond prices sparked concerns about losses in their debt holdings.
State Bank of India fell 3.2 percent, while Punjab National Bank
IDFC Ltd
Hero MotoCorp Ltd
Jaiprakash Associates Ltd
SpiceJet Ltd
Mills, who joined SpiceJet as CEO in 2010, did not answer phone calls. SpiceJet declined to comment.
Macquarie downgraded shares in drug maker Wockhardt Ltd
Wockhardt did not immediately comment about the downgrade. In a statement to the stock exchange on Saturday, the company said it had initiated "several corrective actions" to resolve the concerns raised by the FDA.
However, among stocks that gained, Dabur India Ltd
(Editing by Subhranshu Sahu)